Not finding it? Sign in to also search OpenAlex live.
-
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial
Anna Paula Brandt, Christoph Schultheiß, Konrad Friedrich Klinghammer, Philippe Schafhausen, Chia‐Jung Busch, Markus Blaurock, +8 more
11citations -
UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial
Anna Paula Brandt, Konrad Friedrich Klinghammer, Christoph Schultheiß, Lisa Paschold, Claudia Wickenhauser, Marcus Bauer, +17 more
1citations -
Abstract PS3-08-14: Typer—A randomized controlled trial evaluating the effect of typology-based coaching on therapy management for patients with hr+/her2- early breast cancer under adjuvant ribociclib treatment
M.K. Welslau, Christine Zeder-Goess, Renate Haidinger, B. Welter, B. Aktas, P. Wimberger, +14 more
0citations -
Second-Line Bosutinib Is Effective and Feasible in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) - an Analysis of a Subcohort of the Bodo Trial (CML-VII-study of the German CML Study Group)
Susanne Isfort, Kirsi Marjaana Manz, Lino Lars Teichmann, Martina Margrit Crysandt, Andreas Burchert, Andreas Hochhaus, +18 more
0citations -
Genetic and Epigenetic Changes at Secondary Resistance after Continued Treatment in the Randomized Phase II Study of All-Trans Retinoic Acid (ATRA) and/or Valproic Acid (VPA) Added to Decitabine (DAC) in Newly Diagnosed Elderly AML Patients (DECIDER Trial)
Inga Hund, Maria Elena Hess, Julia Stomper, Gabriele Greve, Jan Mitschke, Christoph Niemöller, +13 more
0citations -
Consensus-Based Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice with a Focus on Patients with Cytopenias: Systematic Literature Review and Clinical Practice Recommendations from a Global Consensus Group
Claire N. Harrison, Prithviraj Bose, Martin H. Ellis, Vikas K Gupta, Jean‐Jacques Kiladjian, John O Mascarenhas, +3 more
1citations -
DEFENDER trial: dapagliflozin for critically ill patients with acute organ dysfunction—implications for clinicians2025 Nephrology Dialysis Transplantation article Medicine Diabetes Treatment and Management Open access
Jolanta Małyszko, Sophie de Seigneux, Vincenzo Cantaluppi, Stanislas Faguer, Joana Gameiro, José António Lopes, +3 more
2citations -
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options
Jean‐Jacques Kiladjian, Francisca Ferrer‐Marín, Haifa Kathrin Al‐Ali, Alberto Álvarez‐Larrán, Eloise Beggiato, Maria Bieniaszewska, +35 more
0citations -
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity
Caterina Maria Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms‐Funke, Irmgard Boesl, Ombretta Caspani, +22 more
10citations -
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)
André Mouraux, Petra Bloms‐Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Giulia Di Stefano, +18 more
6citations -
Effect of platelet-rich fibrin on microperfusion during early socket healing: a randomized controlled clinical trial2025 Clinical Oral Investigations article Medicine Periodontal Regeneration and Treatments Open access
Marie Sophie Katz, Mark Ooms, Marius Heitzer, Maurice Klein, Philipp Winnand, Timm Steiner, +2 more
2citations -
No difference in mobile and fixed bearing partial knee arthroplasty in octogenarians: a clinical trial2023 European Journal of Orthopaedic Surgery & Traumatology article Medicine Total Knee Arthroplasty Outcomes Open access
Riccardo D’Ambrosi, Federico Valli, Alessandro Nuara, Ilaria Mariani, Fabrizio Di Feo, Nicola Ursino, +4 more
10citations -
Bosutinib (BOS) in newly diagnosed chronic myeloid leukemia (CML): Gastrointestinal (GI), liver, effusion, and renal safety characterization in the BFORE trial.
Jörge E. Cortes, Dragana Milojković, Carlo B Gambacorti-Passerini, Valentín García‐Gutiérrez, Michael J. Mauro, Eric P. Leip, +3 more
2citations -
Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma
Christian Straka, Kerstin Schaefer‐Eckart, Bernd Hertenstein, Florian C. Bassermann, Hans Jürgen Salwender, Christian H. Langer, +32 more
17citations -
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial2023 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Steffen Koschmieder, Susanne Isfort, Lutz Jacobasch, Thomas Geer, Marcel Reiser, Michael Koenigsmann, +8 more
13citations -
Effectiveness of Stuttering Modification Treatment in School-Age Children Who Stutter: A Randomized Clinical Trial2023 Journal of Speech Language and Hearing Research article Psychology Stuttering Research and Treatment Open access
Anke Kohmäscher, Annika Primaßin, Sabrina Heiler, Patricia da Costa Avelar, Marie-Christine J. P. Franken, Stefan Heim
10citations